In an interview, the US pharmaceuticals giant’s international chief says Australia has made no progress in making life easier for medicine developers.

The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

Some industries have escaped these moves by the administration, at least for now. One of them is the pharmaceutical industry.

A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

The drugmaker accuses Premier Weight Loss of risking patients' health by selling altered, unsterile versions of its ...

To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...

Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the Food and Drug Administration's ban on the practice and luring people away from ...

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.

While Jasmine didn’t suffer majorly with side effects, she did claim that Mounjaro had a very unexpected impact on her menstrual cycle. Mounjaro, regarded by some as the King Kong of weight ...

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated 1.4 billion people worldwide, including 64 million people in the U.S.